Gilead Sciences, Inc. (GILD) Balance Sheet

NASDAQ: GILDAssets, liabilities, debt and equity over 10 years.

GILD balance sheet, 2025

December 31, 2025 · U.S. dollars

$59.02B assets = $36.41B liabilities + $22.62B equity

What it owns$59.02BCash & ST investments: $9.61B (16.3%)Cash & ST investments$9.61B · 16%Receivables: $4.91B (8.3%)Receivables $4.91BInventory: $1.77B (3.0%)Other current: $2.04B (3.5%)PP&E: $5.61B (9.5%)PP&E $5.61BGoodwill & intangibles: $25.29B (42.9%)Goodwill & intangibles$25.29B · 43%LT investments: $2.97B (5.0%)Other non-current: $6.81B (11.5%)Other non-current$6.81B · 12%=How it is financed$59.02BCurrent liabilities: $11.81B (20.0%)Current liabilities$11.81B · 20%Long-term debt: $22.13B (37.5%)Long-term debt$22.13B · 37%Other LT liabilities: $2.46B (4.2%)Shareholders’ equity: $22.62B (38.3%)Shareholders’ equity$22.62B · 38%

Both columns are drawn to the same scale: what GILD owns equals what it owes plus shareholders’ equity. Hover a block for its value.

GILD financial health

Current ratio1.55
Comfortable · current assets cover current liabilities 1.55×
Debt / equity1.10
Moderate leverage · $1.10 of debt for each $1 of equity
Equity / assets38.5%
Balanced · of assets funded by shareholders
Cash / debt38.6%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles42.9%
Acquisition-heavy · of total assets

Descriptive bands, not a rating. Fiscal 2025.

GILD balance sheet trends, 2016–2025

Gilead Sciences, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$56.98B2016$59.02B2025+0.4%/yr
Total liabilities$37.61B2016$36.41B2025−0.4%/yr
Shareholders’ equity$19.36B2016$22.70B2025+1.8%/yr
Cash & short-term investments$32.38B2016$9.61B2025−12.6%/yr
Total debt$27.75B2016$24.94B2025−1.2%/yr
Net cash (debt)$4.63B2016−$15.32B2025−$19.9B
Working capital$29.26B2016$6.53B2025−$22.7B
Book value per share$14.262016$18.092025+2.7%/yr
Current ratio4.1720161.552025−2.62
Debt / equity1.4320161.102025−0.33
Shares outstanding1.36B20161.25B2025−0.9%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

GILD assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

GILD liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

GILD debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

GILD balance sheet

Gilead Sciences, Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$9.61B$11.57B$7.26B$6.38B$6.52B$7.41B$24.35B$30.09B$25.51B$32.38B
Cash & equivalents$7.56B$9.99B$6.08B$5.41B$5.34B$6.00B$11.63B$17.94B$7.59B$8.23B
Short-term investments$2.05B$1.58B$1.18B$973.0M$1.18B$1.41B$12.72B$12.15B$17.92B$3.67B
Receivables$4.91B$4.42B$4.66B$4.78B$4.49B$4.89B$3.58B$3.33B$3.85B$4.51B
Inventory$1.77B$1.71B$1.79B$1.51B$1.62B$1.68B$922.0M$814.0M$801.0M$1.59B
Other current assets$2.04B$1.48B$2.37B$1.77B$2.14B$2.01B$1.44B$1.61B$1.66B$0
Total current assets$18.34B$19.17B$16.09B$14.44B$14.77B$16.00B$30.30B$35.84B$31.82B$38.48B
Property, plant & equipment (net)$5.61B$5.41B$5.32B$5.47B$5.12B$4.97B$4.50B$4.01B$3.29B$2.87B
Goodwill & intangible assets$25.29B$28.26B$34.77B$37.21B$41.79B$41.23B$17.90B$19.86B$21.26B$10.14B
Long-term investments$2.97B$0$1.16B$1.25B$1.31B$502.0M$1.49B$1.42B$11.18B$20.48B
Other non-current assets$6.81B$6.15B$4.79B$4.80B$4.96B$5.71B$7.44B$2.56B$2.72B$0
Total assets$59.02B$58.99B$62.12B$63.17B$67.95B$68.41B$61.63B$63.67B$70.28B$56.98B
Liabilities
Accounts payable$715.0M$833.0M$550.0M$905.0M$705.0M$844.0M$713.0M$790.0M$814.0M$1.21B
Short-term debt$2.81B$1.81B$1.80B$2.27B$1.52B$2.76B$2.50B$2.75B$2.75B$1.41B
Deferred revenue——−$2.35B—————−$3.56B$202.0M
Total current liabilities$11.81B$12.00B$11.28B$11.24B$11.61B$11.40B$9.76B$10.61B$11.63B$9.22B
Long-term debt$22.13B$24.90B$23.19B$22.96B$25.18B$28.64B$22.09B$24.57B$30.80B$26.35B
Other long-term liabilities$2.46B$2.85B$4.91B$7.77B$10.10B$10.14B$7.12B$6.96B$7.35B$2.05B
Total liabilities$36.41B$39.75B$39.38B$41.96B$46.89B$50.19B$38.98B$42.14B$49.78B$37.61B
Shareholders' equity
Common stock & paid-in capital$1.0M$1.0M$6.50B$5.55B$4.66B$3.88B$3.05B$2.28B$1.26B$455.0M
Retained earnings (deficit)$13.73B$11.50B$16.30B$15.69B$16.32B$14.38B$19.39B$19.02B$19.01B$18.15B
Treasury stock——$0$0$0$0$0$0$0$0
Accumulated other comprehensive income$39.0M$132.0M$28.0M$2.0M$83.0M−$60.0M$85.0M$80.0M$165.0M$278.0M
Minority interest−$84.0M−$84.0M−$84.0M−$31.0M−$5.0M$19.0M$125.0M$147.0M$59.0M$476.0M
Total shareholders' equity$22.70B$19.33B$22.83B$21.24B$21.07B$18.20B$22.52B$21.39B$20.44B$19.36B
Key figures
Total debt$24.94B$26.71B$24.99B$25.23B$26.70B$31.40B$24.59B$27.32B$33.54B$27.75B
Net cash (debt)−$15.32B−$15.14B−$17.72B−$18.84B−$20.18B−$23.99B−$241.0M$2.77B−$8.03B$4.63B
Working capital$6.53B$7.17B$4.80B$3.21B$3.16B$4.60B$20.54B$25.23B$20.19B$29.26B
Tangible book value−$2.59B−$8.93B−$11.94B−$15.97B−$20.72B−$23.03B$4.62B$1.53B−$817.0M$9.22B
Book value per share$18.09$15.40$18.15$16.83$16.69$14.41$17.64$16.35$15.50$14.26
Shares outstanding1.25B1.25B1.26B1.26B1.26B1.26B1.28B1.31B1.32B1.36B
Current ratio1.551.601.431.291.271.403.103.382.744.17
Quick ratio1.231.331.060.990.951.082.863.152.524.00
Debt / equity1.101.381.091.191.271.731.091.281.641.43
Equity / assets38.5%32.8%36.8%33.6%31.0%26.6%36.6%33.6%29.1%34.0%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 24, 2026); data from EODHD.

GILD financial position

At the end of fiscal 2025 (December 31, 2025), Gilead had total assets of $59.0 billion (up 0.0% from a year earlier), total liabilities of $36.4 billion and shareholders' equity of $22.7 billion. It held $9.6 billion in cash and short-term investments against $24.9 billion of debt, net debt of $15.3 billion. Its current ratio was 1.55. In the latest quarter (ended June 30, 2026) total assets were $49.4 billion and equity $11.8 billion.

Related: GILD income statement, GILD cash flow statement, GILD key metrics. See the GILD stock overview for the latest quote and news.

GILD balance sheet FAQ

What are Gilead's total assets?

Gilead reported total assets of $59.0 billion at the end of fiscal 2025 (December 31, 2025), compared with $59.0 billion a year earlier.

How much debt does Gilead have?

Gilead had $24.9 billion of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 1.10.

How much cash does Gilead have?

Gilead held $9.6 billion in cash and short-term investments at the end of fiscal 2025; with $24.9 billion of debt that is net debt of $15.3 billion.

What is Gilead's book value?

Gilead's shareholders' equity (book value) was $22.7 billion at the end of fiscal 2025, or $18.09 per share.

What is Gilead's current ratio?

Gilead had current assets of $18.3 billion and current liabilities of $11.8 billion, a current ratio of 1.55 (it can cover its short-term obligations).

How much goodwill does Gilead have?

Gilead carried $25.3 billion of goodwill and intangible assets, 42.9% of total assets, at the end of fiscal 2025.

Drug Manufacturers - General: balance sheet